Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder

BACKGROUND: This study assessed treatment satisfaction of cystic fibrosis (CF) patients in a routine clinical setting for tobramycin inhalation powder (TIP), the first dry powder–inhaled antibiotic for Pseudomonas aeruginosa infection. METHODS: CF patients aged 6 years or older treated with at least...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenberg, Jonathan, Palmer, Jacqueline B, Chan, Wing W, Correia, Catherine E, Whalley, Diane, Shannon, Paul, Sawicki, Gregory S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087789/
https://www.ncbi.nlm.nih.gov/pubmed/27822017
http://dx.doi.org/10.2147/PPA.S102234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087789/
https://www.ncbi.nlm.nih.gov/pubmed/27822017
http://dx.doi.org/10.2147/PPA.S102234

Ejemplares similares